Abramson Cancer Center multiple myeloma clinicians and researchers have led the way nationally for years in the diagnosis and treatment of multiple myeloma.
Today, there more hope than ever for those diagnosed with multiple myeloma. Our team has worked together for years. By putting our experience to work we offer the best possible treatment outcomes.
If diagnosed with Multiple Myeloma, it's important to have the best team of experts available.
At Penn's Multiple Myeloma Program there are individuals nationally recognized for their expertise. They can provide the information, care and support to help each step of the way.
Penn has one of the few Hematologic Malignancy (leukemia, lymphoma and myeloma) Research Programs in the country that is approved and funded by the National Cancer Institute.
The knowledge gained through our research allows us to better care for those with multiple myeloma.
To learn about what sets us apart, visit:
By the age of seven, Tanya Zekovitch already understood what it was like to be a cancer patient after being treated for Ewing's Sarcoma, a rare form of bone cancer. So when she was diagnosed with Acute Myeloid Leukemia in the summer
Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.
Clinical trials are studies to find new ways to prevent, detect and treat cancer. The purpose of each clinical trial is to answer a specific question. Our physicians carefully design these studies to find new ways to improve care and quality of life ...